Oligonucleotide Synthesis Market Overview
The report is titled as ‘Oligonucleotide Synthesis Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Oligonucleotide Synthesis market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.
Reports & Insights Overview
The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Oligonucleotide Synthesis market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Oligonucleotide Synthesis Market Segmentation
The oligonucleotide synthesis market is segmented on the basis of products & services, type, technology, disease type, nucleic acid type, application, and region.
By Products & Services
Probe
Primer
DNA Oligos
RNA Oligos
Adapters
Other Synthesized Oligos
Reagents
Equipment
Services
Oligo Synthesis
25 nmol
50 nmol
200 nmol
1000 nmol
10,000 nmol
Purification
Modification
By Type
Antisense Oligonucleotide-based Therapies
RNAi Oligonucleotide-based Therapies
CpG Oligonucleotide-based Therapies
By Technology
Column-based
By Disease Type
Infectious Diseases
Other Diseases
RNA
By Application
ASO
siRNA
RNAi
DNA/Antisense
Immunotherapy
Nucleic Acid Aptamers
Others
Research
PCR
Sequencing
qPCR/RTqPCR
Gene Synthesis
Others
Diagnostic
By End User
Academic Research Institutes
CROs and CMOs
Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Oligonucleotide Synthesis Market Key Players
Some of the key participating players in oligonucleotide synthesis market are:
TAG Copenhagen A/S
Quintara Biosciences
Eton Bioscience, Inc.
Kaneka Corporation (Eurogentec)
Bioneer Corporation
GenScript Biotech Corporation
Maravai Life Sciences
Merck KGaA
Danaher Corporation
Thermo Fisher Scientific, Inc.
LGC Biosearch Technologies
Agilent Technologies, Inc.
Biogen Inc.
Sarepta Therapeutics, Inc.
Integrated DNA Technologies, Inc.
Eurofins Scientific SE
Biolegio B.V.
IBA GmbH
TriLink BioTechnologies, LLC
PolyGen GmbH
BioAutomation
Biolytic Lab Performance Inc.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product developments and launches
Global Healthcare Industry Outlook
Oligonucleotide Synthesis Adoption Rate, by End User
Top Companies Historical Growth Rate
Pricing Impact
Advantages of Oligonucleotide Synthesis
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.
To learn more about this report, request a free sample copy
The oligonucleotide synthesis market is estimated to reach at a value of US$ *** Mn by the end of 2022 and expected to reach at a value of US$ *** Mn by 2030 with a significant CAGR of ***%.
The base year for the report is 2021 in oligonucleotide synthesis market.
The oligonucleotide synthesis market is segmented on the basis of products & services, type, technology, disease type, nucleic acid type, application, and region.
Some of the key participating players in oligonucleotide synthesis market are: General Electric Co., TAG Copenhagen A/S, Quintara Biosciences, Eton Bioscience, Inc., Kaneka Corporation (Eurogentec), Bioneer Corporation, GenScript Biotech Corporation, Maravai Life Sciences, Merck KGaA, Danaher Corporation, Thermo Fisher Scientific, Inc., LGC Biosearch Technologies, Agilent Technologies, Inc., Biogen Inc., Sarepta Therapeutics, Inc., Integrated DNA Technologies, Inc., Eurofins Scientific SE, Biolegio B.V., IBA GmbH, TriLink BioTechnologies, LLC, PolyGen GmbH, BioAutomation, Biolytic Lab Performance Inc.